Laminin-511: A multi-functional adhesion protein regulating cell migration, tumor invasion and metastasis

Cell Adhesion and Migration

Volumn 7, Issue 1, 2013, Pages 142-149

  Pouliot, Normand ^a,b   Kusuma, Nicole ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Adhesion; Breast cancer; Extracellular matrix; Integrins; Invasion; Laminin; Metastasis; Migration

Indexed keywords

ALPHA DYSTROGLYCAN; ALPHA6BETA4 INTEGRIN; BASAL CELL ADHESION MOLECULE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; INTEGRIN; KALININ; LAMININ 10; LAMININ 111; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 1; VERY LATE ACTIVATION ANTIGEN 3; VERY LATE ACTIVATION ANTIGEN 6;

ADVANCED CANCER; BREAST CARCINOMA; CANCER INVASION; CANCER PATIENT; CELL MIGRATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG ADENOCARCINOMA; METASTASIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW;

EID: 84872200089     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: 10.4161/cam.22125     Document Type: Review

References (91)

1. Durbeej M. Laminins. Cell Tissue Res 2010; 339:259-68; PMID:19693542; http://dx.doi.org/10.1007/s00441-009-0838-2
2. Timpl R. Macromolecular organization of basement membranes. Curr Opin Cell Biol 1996; 8:618-24; PMID:8939648; http://dx.doi.org/10.1016/S0955-0674(96) 80102-5
3. Aumailley M, Bruckner-Tuderman L, Carter WG, Deutzmann R, Edgar D, Ekblom P, et al. A simplified laminin nomenclature. Matrix Biol 2005; 24:326-32; PMID:15979864; http://dx.doi.org/10.1016/j.matbio.2005.05.006
4. Church HJ, Aplin JD. BeWo choriocarcinoma cells produce laminin 10. Biochem J 1998; 332:491-8; PMID:9601079
5. Kikkawa Y, Sanzen N, Sekiguchi K. Isolation and characterization of laminin-10/11 secreted by human lung carcinoma cells. laminin-10/11 mediates cell adhesion through integrin alpha3 beta1. J Biol Chem 1998; 273:15854-9; PMID:9624186; http://dx.doi.org/10.1074/jbc.273.25.15854
6. Tiger CF, Champliaud MF, Pedrosa-Domellof F, Thornell LE, Ekblom P, Gullberg D. Presence of laminin alpha5 chain and lack of laminin alpha1 chain during human muscle development and in muscular dystrophies. J Biol Chem 1997; 272:28590-5; PMID:9353324; http://dx.doi.org/10.1074/jbc.272.45.28590
7. Timpl R, Rohde H, Robey PG, Rennard SI, Foidart JM, Martin GR. Laminin-a glycoprotein from basement membranes. J Biol Chem 1979; 254:9933-7; PMID:114518
8. Durkin ME, Loechel F, Mattei MG, Gilpin BJ, Albrechtsen R, Wewer UM. Tissue-specific expression of the human laminin alpha5-chain, and mapping of the gene to human chromosome 20q13.2-13.3 and to distal mouse chromosome 2 near the locus for the ragged (Ra) mutation. FEBS Lett 1997; 411:296-300; PMID:9271224; http://dx.doi.org/10.1016/S0014-5793(97)00686-8
9. Miner JH, Lewis RM, Sanes JR. Molecular cloning of a novel laminin chain, alpha 5, and widespread expression in adult mouse tissues. J Biol Chem 1995; 270: 28523-6; PMID:7499364; http://dx.doi.org/10.1074/jbc.270.48.28523
10. Geberhiwot T, Wondimu Z, Salo S, Pikkarainen T, Kortesmaa J, Tryggvason K, et al. Chain specificity assignment of monoclonal antibodies to human laminins by using recombinant laminin beta1 and gamma1 chains. Matrix Biol 2000; 19:163-7; PMID:10842099; http://dx.doi.org/10.1016/S0945-053X(00)00056-1
11. Miner JH, Cunningham J, Sanes JR. Roles for laminin in embryogenesis: exencephaly, syndactyly, and placentopathy in mice lacking the laminin alpha5 chain. J Cell Biol 1998; 143:1713-23; PMID:9852162; http://dx.doi.org/10.1083/ jcb.143.6.1713
12. Fukumoto S, Miner JH, Ida H, Fukumoto E, Yuasa K, Miyazaki H, et al. Laminin alpha5 is required for dental epithelium growth and polarity and the development of tooth bud and shape. J Biol Chem 2006; 281:5008-16; PMID:16365040; http://dx.doi.org/10.1074/jbc.M509295200
13. Li J, Tzu J, Chen Y, Zhang YP, Nguyen NT, Gao J, et al. Laminin-10 is crucial for hair morphogenesis. EMBO J 2003; 22:2400-10; PMID:12743034; http://dx.doi.org/10.1093/emboj/cdg239
14. Mahoney ZX, Stappenbeck TS, Miner JH. Laminin alpha 5 influences the architecture of the mouse small intestine mucosa. J Cell Sci 2008; 121:2493-502; PMID:18628307; http://dx.doi.org/10.1242/jcs.025528
15. Nguyen NM, Kelley DG, Schlueter JA, Meyer MJ, Senior RM, Miner JH. Epithelial laminin alpha5 is necessary for distal epithelial cell maturation, VEGF production, and alveolization in the developing murine lung. Dev Biol 2005; 282:111-25; PMID:15936333; http://dx.doi.org/10.1016/j.ydbio.2005.02.031
16. Rebustini IT, Patel VN, Stewart JS, Layvey A, Georges-Labouesse E, Miner JH, et al. Laminin alpha5 is necessary for submandibular gland epithelial morphogenesis and influences FGFR expression through beta1 integrin signaling. Dev Biol 2007; 308:15-29; PMID:17601529; http://dx.doi.org/10.1016/j.ydbio.2007. 04.031
17. Doi M, Thyboll J, Kortesmaa J, Jansson K, Iivanainen A, Parvardeh M, et al. Recombinant human laminin-10 (alpha5beta1gamma1). Production, purification, and migration-promoting activity on vascular endothelial cells. J Biol Chem 2002; 277:12741-8; PMID: 11821406; http://dx.doi.org/10.1074/jbc.M111228200
18. Pouliot N, Connolly LM, Moritz RL, Simpson RJ, Burgess AW. Colon cancer cells adhesion and spreading on autocrine laminin-10 is mediated by multiple integrin receptors and modulated by EGF receptor stimulation. Exp Cell Res 2000; 261:360-71; PMID:11112342; http://dx.doi.org/10.1006/excr.2000.5065
19. Sroka IC, Chen ML, Cress AE. Simplified purification procedure of laminin-332 and laminin-511 from human cell lines. Biochem Biophys Res Commun 2008; 375:410-3; PMID:18713621; http://dx.doi.org/10.1016/j.bbrc.2008.08.029
20. Zamurs L, Pouliot N, Gibson P, Hocking G, Nice E. Strategies for the purification of laminin-10 for studies on colon cancer metastasis. Biomed Chromatogr 2003; 17:201-11; PMID:12717810; http://dx.doi.org/10.1002/bmc.248
21. Ioachim E, Charchanti A, Briasoulis E, Karavasilis V, Tsanou H, Arvanitis DL, et al. Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression. Eur J Cancer 2002; 38:2362-70; PMID:12460779; http://dx.doi.org/10.1016/S0959-8049(02)00210-1
22. Tagliabue E, Ghirelli C, Squicciarini P, Aiello P, Colnaghi MI, Ménard S. Prognostic value of alpha 6 beta 4 integrin expression in breast carcinomas is affected by laminin production from tumor cells. Clin Cancer Res 1998; 4:407-10; PMID:9516929
23. Engvall E, Earwicker D, Haaparanta T, Ruoslahti E, Sanes JR. Distribution and isolation of four laminin variants; tissue restricted distribution of heterotrimers assembled from five different subunits. Cell Regul 1990; 1:731-40; PMID:2099832
24. Hewitt RE, Powe DG, Morrell K, Balley E, Leach IH, Ellis IO, et al. Laminin and collagen IV subunit distribution in normal and neoplastic tissues of colorectum and breast. Br J Cancer 1997; 75:221-9; PMID:9010030; http://dx.doi.org/10.1038/bjc.1997.37
25. Sollberg S, Peltonen J, Uitto J. Differential expression of laminin isoforms and beta 4 integrin epitopes in the basement membrane zone of normal human skin and basal cell carcinomas. J Invest Dermatol 1992; 98:864-70; PMID:1375618; http://dx.doi.org/10.1111/1523-1747.ep12457080
26. Hallmann R, Horn N, Selg M, Wendler O, Pausch F, Sorokin LM. Expression and function of laminins in the embryonic and mature vasculature. Physiol Rev 2005; 85:979-1000; PMID:15987800; http://dx.doi.org/10.1152/physrev.00014.2004
27. Määttä M, Virtanen I, Burgeson R, Autio-Harmainen H. Comparative analysis of the distribution of laminin chains in the basement membranes in some malignant epithelial tumors: the alpha1 chain of laminin shows a selected expression pattern in human carcinomas. J Histochem Cytochem 2001; 49:711-26; PMID:11373318; http://dx.doi.org/10.1177/002215540104900605
28. Brar PK, Dalkin BL, Weyer C, Sallam K, Virtanen I, Nagle RB. Laminin alpha-1, alpha-3, and alpha-5 chain expression in human prepubertal [correction of prepubetal] benign prostate glands and adult benign and malignant prostate glands. Prostate 2003; 55:65-70; PMID:12640662; http://dx.doi.org/10.1002/pros. 10206
29. Chia J, Kusuma N, Anderson R, Parker B, Bidwell B, Zamurs L, et al. Evidence for a role of tumor-derived laminin-511 in the metastatic progression of breast cancer. Am J Pathol 2007; 170:2135-48; PMID:17525279; http://dx.doi.org/10.2353/ajpath.2007.060709
30. Fujita M, Khazenzon NM, Bose S, Sekiguchi K, Sasaki T, Carter WG, et al. Overexpression of beta1-chain-containing laminins in capillary basement membranes of human breast cancer and its metastases. Breast Cancer Res 2005; 7:R411-21; PMID:15987446; http://dx.doi.org/10.1186/bcr1011
31. Oikawa Y, Hansson J, Sasaki T, Rousselle P, Domogatskaya A, Rodin S, et al. Melanoma cells produce multiple laminin isoforms and strongly migrate on α5 laminin(s) via several integrin receptors. Exp Cell Res 2011; 317:1119-33; PMID:21195710; http://dx.doi.org/10.1016/j.yexcr.2010.12.019
32. Kawataki T, Yamane T, Naganuma H, Rousselle P, Andurén I, Tryggvason K, et al. Laminin isoforms and their integrin receptors in glioma cell migration and invasiveness: Evidence for a role of alpha5-laminin (s) and alpha3beta1 integrin. Exp Cell Res 2007; 313: 3819-31; PMID:17888902; http://dx.doi.org/10.1016/j.yexcr.2007.07.038
33. Franz M, Wolheim A, Richter P, Umbreit C, Dahse R, Driemel O, et al. Stromal laminin chain distribution in normal, hyperplastic and malignant oral mucosa: relation to myofibroblast occurrence and vessel formation. J Oral Pathol Med 2010; 39:290-8; PMID:19889153
34. Nagle RB, Knox JD, Wolf C, Bowden GT, Cress AE. Adhesion molecules, extracellular matrix, and proteases in prostate carcinoma. J Cell Biochem Suppl 1994; 19: 232-7; PMID:7823596
35. Szelachowska J, Jelen M. Laminin, Her2/neu and Ki-67 as prognostic factors in non-small cell lung cancer. Rocz Akad Med Bialymst 2004; 49:256-61; PMID:15631353
36. Gusterson BA, Warburton MJ, Mitchell D, Ellison M, Neville AM, Rudland PS. Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases. Cancer Res 1982; 42:4763-70; PMID:6290045
37. Albrechtsen R, Nielsen M, Wewer U, Engvall E, Ruoslahti E. Basement membrane changes in breast cancer detected by immunohistochemical staining for laminin. Cancer Res 1981; 41:5076-81; PMID:7030483
38. Eckhardt BL, Parker BS, van Laar RK, Restall CM, Natoli AL, Tavaria MD, et al. Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix. Mol Cancer Res 2005; 3:1-13; PMID:15671244
39. Carpenter PM, Wang-Rodriguez J, Chan OT, Wilczynski SP. Laminin 5 expression in metaplastic breast carcinomas. Am J Surg Pathol 2008; 32:345-53; PMID:18300817; http://dx.doi.org/10.1097/PAS.0b013e3181592201
40. Gonzalez-Angulo AM, Sahin A, Krishnamurthy S, Yang Y, Kau SW, Hortobagyi GN, et al. Biologic markers in axillary node-negative breast cancer: differential expression in invasive ductal carcinoma versus invasive lobular carcinoma. Clin Breast Cancer 2006; 7:396-400; PMID:17239264; http://dx.doi.org/10.3816/CBC.2006.n.056
41. Gudjonsson T, Rønnov-Jessen L, Villadsen R, Rank F, Bissell MJ, Petersen OW. Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J Cell Sci 2002; 115:39-50; PMID:11801722
42. Henning K, Berndt A, Katenkamp D, Kosmehl H. Loss of laminin-5 in the epithelium-stroma interface: an immunohistochemical marker of malignancy in epithelial lesions of the breast. Histopathology 1999; 34:305-9; PMID:10231397; http://dx.doi.org/10.1046/j.1365-2559.1999.00634.x
43. Korah R, Das K, Lindy ME, Hameed M, Wieder R. Coordinate loss of fibroblast growth factor 2 and laminin 5 expression during neoplastic progression of mammary duct epithelium. Hum Pathol 2007; 38:154-60; PMID:16996573; http://dx.doi.org/10.1016/j.humpath.2006.07.004
44. Martin KJ, Kwan CP, Nagasaki K, Zhang X, O'Hare MJ, Kaelin CM, et al. Down-regulation of laminin-5 in breast carcinoma cells. Mol Med 1998; 4:602-13; PMID:9848077
45. Coleman RE. Skeletal complications of malignancy. Cancer 1997; 80(Suppl):1588-94; PMID:9362426; http://dx.doi.org/10.1002/(SICI)1097- 0142(19971015)80:8+〈1588::AID-CNCR9〉3.0.CO;2-G
46. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 2006; 12:6243s-9s; PMID:17062708; http://dx.doi.org/10.1158/1078-0432.CCR-06-0931
47. Bao L, Haque A, Jackson K, Hazari S, Moroz K, Jetly R, et al. Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer model. Am J Pathol 2011; 178:838-52; PMID:21281816; http://dx.doi.org/10.1016/j.ajpath.2010.10.029
48. Pal SK, Childs BH, Pegram M. Triple negative breast cancer: unmet medical needs. Breast Cancer Res Treat 2011; 125:627-36; PMID:21161370; http://dx.doi.org/10.1007/s10549-010-1293-1
49. Kim BG, An HJ, Kang S, Choi YP, Gao MQ, Park H, et al. Laminin-332-rich tumor microenvironment for tumor invasion in the interface zone of breast cancer. Am J Pathol 2011; 178:373-81; PMID:21224074; http://dx.doi.org/10.1016/ j.ajpath.2010.11.028
50. Kim BG, Gao MQ, Choi YP, Kang S, Park HR, Kang KS, et al. Invasive breast cancer induces laminin-332 upregulation and integrin β4 neoexpression in myofibroblasts to confer an anoikis-resistant phenotype during tissue remodeling. Breast Cancer Res 2012; 14:R88; PMID:22673183; http://dx.doi.org/10. 1186/bcr3203
51. Tani T, Lehto VP, Virtanen I. Expression of laminins 1 and 10 in carcinoma cells and comparison of their roles in cell adhesion. Exp Cell Res 1999; 248:115-21; PMID:10094819; http://dx.doi.org/10.1006/excr.1999.4399
52. Spessotto P, Gronkowska A, Deutzmann R, Perris R, Colombatti A. Preferential locomotion of leukemic cells towards laminin isoforms 8 and 10. Matrix Biol 2003; 22:351-61; PMID:12935819; http://dx.doi.org/10.1016/S0945- 053X(03)00050-7
53. Ferletta M, Ekblom P. Identification of laminin-10/11 as a strong cell adhesive complex for a normal and a malignant human epithelial cell line. J Cell Sci 1999; 112:1-10; PMID:9841899
54. Wondimu Z,GorfuG, Kawataki T, Smirnov S, Yurchenco P, Tryggvason K, et al. Characterization of commercial laminin preparations from human placenta in comparison to recombinant laminins 2 (alpha2beta1gamma1), 8 (alpha4beta1gamma1), 10 (alpha5beta1gamma1). Matrix Biol 2006; 25:89-93; PMID:16289578; http://dx.doi.org/10.1016/j.matbio.2005.10.001
55. Ido H, Harada K, Futaki S, Hayashi Y, Nishiuchi R, Natsuka Y, et al. Molecular dissection of the alpha-dystroglycan- and integrin-binding sites within the globular domain of human laminin-10. J Biol Chem 2004; 279:10946-54; PMID:14701821; http://dx.doi.org/10.1074/jbc.M313626200
56. Kikkawa Y, Miner JH. Review: Lutheran/B-CAM: a laminin receptor on red blood cells and in various tissues. Connect Tissue Res 2005; 46:193-9; PMID:16546822; http://dx.doi.org/10.1080/03008200500344074
57. Kikkawa Y, Sasaki T, Nguyen MT, Nomizu M, Mitaka T, Miner JH. The LG1-3 tandem of laminin alpha5 harbors the binding sites of Lutheran/basal cell adhesion molecule and alpha3beta1/alpha6beta1 integrins. J Biol Chem 2007; 282:14853-60; PMID:17383963; http://dx.doi.org/10.1074/jbc.M611706200
58. Sugawara K, Tsuruta D, Ishii M, Jones JC, Kobayashi H. Laminin-332 and -511 in skin. Exp Dermatol 2008; 17:473-80; PMID:18474082; http://dx.doi.org/10. 1111/j.1600-0625.2008.00721.x
59. Nishiuchi R, Takagi J, Hayashi M, Ido H, Yagi Y, Sanzen N, et al. Ligand-binding specificities of laminin-binding integrins: a comprehensive survey of laminin-integrin interactions using recombinant alpha3beta1, alpha6beta1, alpha7beta1 and alpha6beta4 integrins. Matrix Biol 2006; 25:189-97; PMID:16413178; http://dx.doi.org/10.1016/j.matbio.2005.12.001
60. Kikkawa Y, Sudo R, Kon J, Mizuguchi T, Nomizu M, Hirata K, et al. Laminin alpha 5 mediates ectopic adhesion of hepatocellular carcinoma through integrins and/or Lutheran/basal cell adhesion molecule. Exp Cell Res 2008; 314:2579-90; PMID:18635166; http://dx.doi.org/10.1016/j.yexcr.2008.05.021
61. Pouliot N, Nice EC, Burgess AW. Laminin-10 mediates basal and EGF-stimulated motility of human colon carcinoma cells via alpha(3)beta(1) and alpha(6) beta(4) integrins. Exp Cell Res 2001; 266:1-10; PMID:11339819; http://dx.doi.org/10.1006/excr.2001.5197
62. Lipscomb EA, Simpson KJ, Lyle SR, Ring JE, Dugan AS, Mercurio AM. The alpha6beta4 integrin maintains the survival of human breast carcinoma cells in vivo. Cancer Res 2005; 65:10970-6; PMID:16322245; http://dx.doi.org/10.1158/ 0008-5472.CAN-05-2327
63. Mercurio AM, Bachelder RE, Chung J, O'Connor KL, Rabinovitz I, Shaw LM, et al. Integrin laminin receptors and breast carcinoma progression. J Mammary Gland Biol Neoplasia 2001; 6:299-309; PMID:11547899; http://dx.doi.org/10.1023/ A:1011323608064
64. Morini M, Mottolese M, Ferrari N, Ghiorzo F, Buglioni S, Mortarini R, et al. The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. Int J Cancer 2000; 87:336-42; PMID:10897037; http://dx.doi.org/10.1002/1097-0215(20000801)87: 3〈336::AID-IJC5〉3.0.CO;2-3
65. Soung YH, Gil HJ, Clifford JL, Chung J. Role of a6!4 integrin in cell motility, invasion and metastasis of mammary tumors. Curr Protein Pept Sci 2011; 12:23-9; PMID:21190525
66. Stipp CS. Laminin-binding integrins and their tetraspanin partners as potential antimetastatic targets. Expert Rev Mol Med 2010; 12:e3; PMID:20078909; http://dx.doi.org/10.1017/S1462399409001355
67. Subbaram S, Dipersio CM. Integrin a3!1 as a breast cancer target. Expert Opin Ther Targets 2011; 15: 1197-210; PMID:21838596; http://dx.doi.org/10.1517/ 14728222.2011.609557
68. Weaver VM, Lelièvre S, Lakins JN, Chrenek MA, Jones JC, Giancotti F, et al. beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell 2002; 2:205-16; PMID:12242153; http://dx.doi.org/10. 1016/S1535-6108(02)00125-3
69. Wewer UM, Shaw LM, Albrechtsen R, Mercurio AM. The integrin alpha 6 beta 1 promotes the survival of metastatic human breast carcinoma cells in mice. Am J Pathol 1997; 151:1191-8; PMID:9358743
70. Eble JA, Bruckner P, Mayer U. Vipera lebetina venom contains two disintegrins inhibiting laminin-binding beta1 integrins. J Biol Chem 2003; 278:26488-96; PMID: 12719418; http://dx.doi.org/10.1074/jbc.M301860200
71. Kusuma N, Denoyer D, Eble JA, Redvers RP, Parker BS, Pelzer R, et al. Integrin-dependent response to laminin-511 regulates breast tumor cell invasion and metastasis. Int J Cancer 2012; 130:555-66; PMID:21387294; http://dx.doi.org/10.1002/ijc.26018
72. Plopper GE, Domanico SZ, Cirulli V, Kiosses WB, Quaranta V. Migration of breast epithelial cells on Laminin-5: differential role of integrins in normal and transformed cell types. Breast Cancer Res Treat 1998; 51:57-69; PMID:9877029; http://dx.doi.org/10.1023/A:1006086218174
73. Kusuma N, Anderson RL, Pouliot N. Laminin α5-derived peptides modulate the properties of metastatic breast tumour cells. Clin Exp Metastasis 2011; 28:909-21; PMID:21938437; http://dx.doi.org/10.1007/s10585-011-9422-8
74. Lu S, Simin K, Khan A, Mercurio AM. Analysis of integrin beta4 expression in human breast cancer: association with basal-like tumors and prognostic significance. Clin Cancer Res 2008; 14:1050-8; PMID:18281537; http://dx.doi.org/10.1158/1078-0432.CCR-07-4116
75. IdoH,Harada K, Yagi Y, Sekiguchi K. Probing the integrin-binding site within the globular domain of laminin-511 with the function-blocking monoclonal antibody 4C7. Matrix Biol 2006; 25:112-7; PMID:16324831; http://dx.doi.org/10. 1016/j.matbio.2005.10.003
76. Domogatskaya A, Rodin S, Boutaud A, Tryggvason K. Laminin-511 but not -332, -111, or -411 enables mouse embryonic stem cell self-renewal in vitro. Stem Cells 2008; 26:2800-9; PMID:18757303; http://dx.doi.org/10.1634/stemcells. 2007-0389
77. Rodin S, Domogatskaya A, Ström S, Hansson EM, Chien KR, Inzunza J, et al. Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511. Nat Biotechnol 2010; 28:611-5; PMID:20512123; http://dx.doi.org/10.1038/nbt.1620
78. Takkunen M, Ainola M, Vainionpää N, Grenman R, Patarroyo M, García de Herreros A, et al. Epithelial-mesenchymal transition downregulates laminin alpha5 chain and upregulates laminin alpha4 chain in oral squamous carcinoma cells. Histochem Cell Biol 2008; 130:509-25; PMID:18496706; http://dx.doi.org/10.1007/s00418-008-0443-6
79. Takkunen M, Grenman R, Hukkanen M, Korhonen M, García de Herreros A, Virtanen I. Snail-dependent and -independent epithelial-mesenchymal transition in oral squamous carcinoma cells. J Histochem Cytochem 2006; 54:1263-75; PMID:16899764; http://dx.doi.org/10.1369/jhc.6A6958.2006
80. Banerjee M, Virtanen I, Palgi J, Korsgren O, Otonkoski T. Proliferation and plasticity of human beta cells on physiologically occurring laminin isoforms. Mol Cell Endocrinol 2012; 355:78-86; PMID:22314207; http://dx.doi.org/10.1016/j.mce.2012.01.020
81. Ke AW, Shi GM, Zhou J, Huang XY, Shi YH, Ding ZB, et al. CD151 amplifies signaling by integrin α6β1 to PI3K and induces the epithelial-mesenchymal transition in HCC cells. Gastroenterology 2011; 140: 1629-41, e15; PMID:21320503; http://dx.doi.org/10.1053/j.gastro.2011.02.008
82. Yang W, Li P, Lin J, Zuo H, Zuo P, Zou Y, et al. CD151 promotes proliferation and migration of PC3 cells via the formation of CD151-integrin α3/α6 complex. J Huazhong Univ Sci Technolog Med Sci 2012; 32:383-8; PMID:22684562; http://dx.doi.org/10.1007/s11596-012-0066-y
83. Kwon MJ, Park S, Choi JY, Oh E, Kim YJ, Park YH, et al. Clinical significance of CD151 overexpression in subtypes of invasive breast cancer. Br J Cancer 2012; 106:923-30; PMID:22294188; http://dx.doi.org/10.1038/bjc.2012.11
84. Hibino S, Shibuya M, Engbring JA, Mochizuki M, Nomizu M, Kleinman HK. Identification of an active site on the laminin alpha5 chain globular domain that binds to CD44 and inhibits malignancy. Cancer Res 2004; 64:4810-6; PMID:15256450; http://dx.doi.org/10.1158/0008-5472.CAN-04-0129
85. Iwamoto Y, Robey FA, Graf J, Sasaki M, Kleinman HK, Yamada Y, et al. YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation. Science 1987; 238:1132-4; PMID:2961059; http://dx.doi.org/10.1126/ science.2961059
86. Nakai M, Mundy GR, Williams PJ, Boyce B, Yoneda T. A synthetic antagonist to laminin inhibits the formation of osteolytic metastases by human melanoma cells in nude mice. Cancer Res 1992; 52:5395-9; PMID:1394144
87. Ponce ML, Kleinman HK. Identification of redundant angiogenic sites in laminin alpha1 and gamma1 chains. Exp Cell Res 2003; 285:189-95; PMID:12706114; http://dx.doi.org/10.1016/S0014-4827(03)00056-9
88. McLane MA, Sanchez EE, Wong A, Paquette-Straub C, Perez JC. Disintegrins. Curr Drug Targets Cardiovasc Haematol Disord 2004; 4:327-55; PMID:15578957; http://dx.doi.org/10.2174/1568006043335880
89. Rosenow F, Ossig R, Thormeyer D, Gasmann P, Schlüter K, Brunner G, et al. Integrins as antimetastatic targets of RGD-independent snake venom components in liver metastasis [corrected][corrected]. Neoplasia 2008; 10:168-76; PMID:18283339; http://dx.doi.org/10.1593/neo.07898
90. Gu J, Nishiuchi R, Sekiguchi K. Matrix metalloproteinase-2 is involved in A549 cell migration on laminin-10/11. Biochem Biophys Res Commun 2002; 296:73-7; PMID:12147229; http://dx.doi.org/10.1016/S0006-291X(02)00831-8
91. Wang H, Fu W, Im JH, Zhou Z, Santoro SA, Iyer V, et al. Tumor cell alpha3beta1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis. J Cell Biol 2004; 164:935-41; PMID:15024036; http://dx.doi.org/10. 1083/jcb.200309112